Bruno Silva-Santos

Company: Instituto de Medicina Molecular

Job title: Group Leader

Seminars:

Tumor targeting by Boosted & (CAR-) Engineered Delta One T cells 11:30 am

Elucidating how Delta One T (DOT) cells target tumors via NK cell receptors/ ligands Comparing the anti-tumor efficacy of DOT and CAR-DOT cells in patient-derived xenografts, including upon tumor re-challenge Discussing the importance of cytokines in the persistence and efficacy of (CAR-) DOT cells in vivoRead more

day: Day 1 am track b